Cargando…
The Promises of Speeding Up: Changes in Requirements for Animal Studies and Alternatives during COVID-19 Vaccine Approval–A Case Study
SIMPLE SUMMARY: The COVID-19 pandemic led to intensive research into finding new vaccines for human protection. On 21 December 2020, the European Commission granted conditional marketing authorisation for the messenger RNA vaccine ‘Comirnaty’, produced by Pfizer (New York, NY, USA) and BioNTech (Mai...
Autores principales: | Ritskes-Hoitinga, Merel, Barella, Yari, Kleinhout-Vliek, Tineke |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9264994/ https://www.ncbi.nlm.nih.gov/pubmed/35804634 http://dx.doi.org/10.3390/ani12131735 |
Ejemplares similares
-
Can prospective systematic reviews of animal studies improve clinical translation?
por: Pound, Pandora, et al.
Publicado: (2020) -
Implementing pharmaceutical track-and-trace systems: a realist review
por: Kootstra, Joeke, et al.
Publicado: (2021) -
Is it possible to overcome issues of external validity in preclinical animal research? Why most animal models are bound to fail
por: Pound, Pandora, et al.
Publicado: (2018) -
Necessity under construction – societal weighing rationality in the appraisal of health care technologies
por: Kleinhout-Vliek, Tineke, et al.
Publicado: (2021) -
How Can Systematic Reviews Teach Us More about the Implementation of the 3Rs and Animal Welfare?
por: Ritskes-Hoitinga, Merel, et al.
Publicado: (2019)